Article
Study of a panel of genetic mutations in fibrocalcific pancreatic diabetes (FCPD): SPINK1 (N34S) mutation unlikely to be relevant.
Scientific reports - 30 Dec 2024
Budhwar Vijay, Dutta Susmita, Pandit Kaushik, Mukhopadhyay Pradip, Bhattacharyya Nitai P, Ghosh Sujoy
Abstract excerpt
Panel of known genetic mutations (SPINK1, PRSS1, PRSS2, CTRC, and CFTR) in patients with Fibrocalcific pancreatic diabetes (FCPD)compared to Type 2 Diabetes (T2DM) and healthy controls with emphasis on SPINK1 (N34S) mutations. Whole blood samples were used to detect mutations by PCR followed by Sanger sequencing. In-silico analysis of N34S performed, to explore role in pathogenesis. Isolated SPINK1 N34S mutations...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
